CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]
Revenue	$ 7,762,183	$ 4,686,312	$ 22,294,439	$ 14,340,791
Costs and Expenses:
Cost of revenues	3,753,561	1,402,920	10,113,352	4,913,195
Research and development	676,172	291,962	1,958,140	989,052
Sales and marketing	1,461,348	956,983	4,339,785	3,029,783
General and administrative	2,118,273	2,858,184	7,369,326	9,371,430
Litigation settlements and related expenses	0	1,394	0	1,152,670
Depreciation and amortization	52,135	6,629	155,586	23,405
Strategic review and transaction related expenses	170,579	(35,931)	176,724	399,913
Total costs and expenses	8,232,068	5,482,141	24,112,913	19,879,448
Operating Loss	(469,885)	(795,829)	(1,818,474)	(5,538,657)
Other Income (Expense):
Change in fair value of warrant liability	0	20	0	563
Interest and investment income	336,002	658,339	1,012,818	1,951,812
Gain on sale of investment	0	32,082	0	80,694
Interest expense	(35,984)	(195,415)	(142,351)	(587,684)
Gain on debt redemption	0	0	0	137,356
Total other income, net	300,018	495,026	870,467	1,582,741
Net loss before income taxes	(169,867)	(300,803)	(948,007)	(3,955,916)
Income tax benefit (expense)	18,647	95,896	(104,282)	(14,865)
Net loss	$ (151,220)	$ (204,907)	$ (1,052,289)	$ (3,970,781)
Basic net income (loss) per common share (in Dollars per share)	$ 0	$ (0.01)	$ (0.03)	$ (0.13)
Diluted net income (loss) per common share (in Dollars per share)	$ 0	$ (0.01)	$ (0.03)	$ (0.13)
Weighted-average shares outstanding - basic (in Shares)	31,082,725	31,098,180	31,136,376	31,064,418
Weighted-average shares outstanding - diluted (in Shares)	31,082,725	31,098,180	31,136,376	31,064,418